Bosh sahifaONCY • NASDAQ
add
Oncolytics Biotech Inc
0,69 $
Seans yopilganidan keyin:(3,61%)+0,025
0,72 $
Yopilgan:20-iyn, 20:00:00 (GMT-4) · USD · NASDAQ · Ogohlantirish
Yopilish kursi
0,74 $
Kunlik diapazon
0,69 $ - 0,77 $
Yillik diapazon
0,33 $ - 1,53 $
Bozor kapitalizatsiyasi
58,65 mln USD
Oʻrtacha hajm
1,08 mln
Narx/foyda
-
Dividend daromadliligi
-
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (CAD) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | — | — |
Joriy xarajat | 7,00 mln | -19,79% |
Sof foyda | -6,69 mln | 3,00% |
Sof foyda marjasi | — | — |
Har bir ulushga tushum | -0,08 | 11,11% |
EBITDA | -6,97 mln | 19,83% |
Amaldagi soliq stavkasi | — | — |
Balans
Jami aktivlari
Jami passivlari
| (CAD) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 15,30 mln | -48,31% |
Jami aktivlari | 19,70 mln | -43,30% |
Jami passivlari | 13,21 mln | 12,11% |
Umumiy kapital | 6,49 mln | — |
Tarqatilgan aksiyalar | 88,82 mln | — |
Narxi/balansdagi bahosi | 9,25 | — |
Aktivlardan daromad | -87,73% | — |
Kapitaldan daromad | -240,66% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (CAD) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | -6,69 mln | 3,00% |
Operatsiyalardan naqd pul | -6,50 mln | 13,00% |
Sarmoyadan naqd pul | — | — |
Moliyadan naqd pul | 5,89 mln | 293,98% |
Naqd pulning sof oʻzgarishi | -639,00 ming | 87,96% |
Boʻsh pul | -4,25 mln | 22,67% |
Haqida
Oncolytics Biotech Inc. is a Canadian company headquartered in Calgary, Alberta, that is developing an intravenously delivered immuno-oncolytic virus called pelareorep for the treatment of solid tumors and hematological malignancies. Pelareorep is a non-pathogenic, proprietary isolate of the unmodified reovirus that: induces selective tumor lysis and promotes an inflamed tumor phenotype through innate and adaptive immune responses. Wikipedia
Tashkil etilgan
1998
Bosh ofis
Xodimlar soni
28
